Manveo Meningococcal Vaccine, Group A, C, Y & W-135
C, Group A, Meningococcal Vaccine, Y & W-135
Meningococcal Vaccine, Group A, C, Y & W-135 active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
Technical Specifications
| Drug Composition | C, Group A, Meningococcal Vaccine, Y & W-135 |
|---|---|
| Variant / Strength | '- |
| Dosage Form / Type | Injectables |
| Product Benefits | Prevention of Meningococcal disease |
| Packaging Type | Vial |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
Product Overview & Description
The vaccine is employed to guard against meningococcal disease, serving as active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
Submit Quotation Request
Verified Customer Reviews (0)